Breaks Categories: News

ThursdayFeb 13, 2020 10:58 am

NetworkNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Announces Reshaping of its Board of Directors

Youngevity International (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise and its newly acquired commercial hemp enterprise, today announced the reshaping of its Board of Directors. According to the update, effective February 11, 2020, in order to maintain compliance with The Nasdaq Capital Market’s corporate governance requirements and, specifically, Listing Rule 5605(b) which provides that a listed company's board of directors shall be comprised of a majority of independent directors, Michelle Wallach and Richard Renton, two non-independent members of the Board of Directors of YGYI resigned as members of the Board…

Continue Reading

ThursdayFeb 13, 2020 10:51 am

NetworkNewsBreaks – Endonovo Therapeutics, Inc. (ENDV) Collaborates with a Stanford University Sponsored Orthopedic Shoulder and Knee Study

Endonovo Therapeutics (OTCQB: ENDV) today announced its collaboration with a Stanford University sponsored Orthopedic Shoulder and Knee Study to determine benefits of Endonovo's tPEMF SofPulse(R) on pain, medication levels and physical function post-operatively. According to the update, the study will evaluate 76 patients with Active and Sham Comparator groups, measured by visual analog scale (“VAS”), at 10 days after, and will allow surgeons to determine postoperative efficacy of Endonovo's SofPulse(R) tPEMF portable device. “The study will allow surgeons to determine if PEMF SofPulse(R) therapy is beneficial in reducing patient-reported post-operative pain,” Endonovo CMO, Dr. Nev Zubcevik DO, said in the…

Continue Reading

ThursdayFeb 13, 2020 10:09 am

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH(TM)-Enabled CBD Infused Powders Available for Sale Across the US

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that its DehydraTECH(TM)-enabled CBD infused powders are now available for sale across the U.S. to businesses wanting to produce topicals and edibles with clinically proven performance for increased consumer satisfaction and improved stability. Consumers of both CBD/hemp and cannabis have recently become concerned about the potency and safety of the oil extract products they are purchasing. Lexaria's patented DehydraTECH(TM) technology and powder processing methodology, similar to a pasteurization technique in some ways, helps to not only preserve cannabinoid potency but also to reduce or eliminate…

Continue Reading

ThursdayFeb 13, 2020 9:58 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Reveals Results from New BIGresearch Valentine’s Day Report

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, this morning released results from its BIGresearch study. The study of over 53,000 Americans was conducted in January 2020 and the results uncover this year's Valentine's Day consumer behaviors and opinions. Among other highlights, the study found that 79% of people celebrating this year are between the ages of 18 and 34, with 47% between 25 and 34. The report also includes detailed information based on shopping surveys, with results broken out by gender, age, household income, and ethnicity. “Changing values and opinions in consumers greatly affect their…

Continue Reading

ThursdayFeb 13, 2020 9:28 am

NetworkNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Inks Supply Agreement with International Land Mobile Radio & Software Vendor

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) this morning reported that it has signed a multi-year supply agreement with a global land mobile radio (“LMR”) and software vendor. Per the agreement, Siyata Mobile will supply the Uniden(R) UV350 in-vehicle IoT device to the vendor for resale to first responder and commercial fleet customers wanting to improve their current in-vehicle communication hardware with next generation IoT solutions. “We are very excited to finalize this agreement with the dominant LMR vendor in the public safety and commercial fleet market worldwide. Our UV350 dedicated in-vehicle IoT device allows them to provide their customers with…

Continue Reading

WednesdayFeb 12, 2020 1:56 pm

NetworkNewsBreaks – Jeb Bush to Present Prize to Channelchek College Challenge Winner at NobleCon16

Noble Capital Markets, Inc. (“Noble”) today announced details on its plans to present the winner of the first annual Channelchek Microcap Equity Research Report Contest (the “Channelchek College Challenge”) at its upcoming small and microcap conference (NobleCon16). According to the update, conference keynote Governor Jeb Bush (Florida, 1999-2007) will present the prize to the winner on the morning of February 17, 2020. “This challenge brought in a large number of submissions from well-known business schools, state schools, and small private colleges throughout the country,” Noble Capital Markets Director of Research Michael Kupinski said in the news release. “It was great…

Continue Reading

WednesdayFeb 12, 2020 1:52 pm

NetworkNewsBreaks – Event Team Takes Concierge Approach in Connecting Opportunity with Capital at Investor Summit

The Investor Summit, the East Coast’s premier investor conference, today announced details for its upcoming spring summit scheduled to take place at The Essex House in New York City on March 25-26, 2020. The Investor Summit team takes a concierge approach in connecting executives with investors, drawn from across the country to participate in the event’s unique delegate program. The two-day event will feature approximately 160 presenting companies, which will take the stage to share insight, offerings and the latest trends across multiple sectors including healthcare, technology, consumer, cannabis, financial, blockchain, energy, and others. “We take great pride in the…

Continue Reading

WednesdayFeb 12, 2020 12:31 pm

NetworkNewsBreaks – Daré Bioscience, Inc. (NASDAQ: DARE) Featured in ROTH Equity Research Report

Daré Bioscience (NASDAQ: DARE) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “With DARE’s recent exclusive licensing deal with Bayer for Ovaprene totaling $310M in milestone payments (excluding double digit royalties) and a $20M payment after pivotal study completion, we will talk to Dr. Thurman, Associate Professor of OB/GYN and Director of Resident Research at EVMS, to figure out Ovaprene’s value proposition as a novel contraceptive. We will also discuss DARE-BV1's existing dataset and its clinical potential for the treatment of bacterial vaginosis (BV).” To request access to the full report,…

Continue Reading

WednesdayFeb 12, 2020 12:29 pm

NetworkNewsBreaks – Albireo Pharma, Inc. (NASDAQ: ALBO) Featured in ROTH Equity Research Report

Albireo Pharma (NASDAQ: ALBO) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “Last Wednesday, ALBO announced a trio of key clinical updates across three different liver indications, with the most imminent being Ph3 readout for odevixibat in PFIC in mid 2020, followed by a pivotal trial in biliary atresia in 1H20 as well as a pivotal study in Alagille syndrome by YE20. See below for our thoughts below on why these clinical developments will make 2020 a fruitful year for ALBO.” To request access to the full report, visit http://nnw.fm/DXCr3 About…

Continue Reading

WednesdayFeb 12, 2020 12:24 pm

NetworkNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Featured in ROTH Equity Research Report

INmune Bio (NASDAQ: INMB) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “Last week, we hosted INMB management meetings in New York and conclude that even early clinical success with any one of its programs would justify our valuation. We view INMB's DN-TNF platform to be a highly rational and safe approach to several diseases that are increasingly associated with surreptitious chronic inflammation. Earlier stage cancer therapy INKmune has advantages to other NK cell therapies including no removal of patient NK cells, a one size fits all approach, and substantially lower…

Continue Reading